A Preliminary Study of Prophylactic Fentanyl Buccal Tablets (FBT) for Exercise Induced Breakthrough Dyspnea
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2017
Price : $35 *
At a glance
- Drugs Fentanyl (Primary)
- Indications Dyspnoea
- Focus Therapeutic Use
- 02 Jun 2017 Results analysing the effect of prophylactic fentanyl buccal tablet (FBT) on exertional dyspnea in patients with cancer, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 31 May 2017 Planned primary completion date changed from 1 May 2018 to 1 May 2019.
- 27 May 2016 Status changed from recruiting to active, no longer recruiting.